【摘要】 目的总结肝癌合并门静脉高压症联合手术治疗的临床疗效。方法对我院2000年6月-2008年12月期间,32例肝癌合并门静脉高压症联合手术治疗患者和同期26例肝癌合并门静脉高压症行单纯切除患者的1年生存率、3年生存率、5年生存率、再出血率进行回顾性分析。结果联合手术组(n=32)的1年生存率(68.75%),3年生存率(56.25%),再出血率(12.5%)均比单纯切除组(n=26)的1年生存率(42.31%),3年生存率(23.08%),再出血率(57.69%)有显著意义(P<0.05)。但5年生存率无显著差别(P>0.05)。结论肝癌合并门静脉高压症联合手术治疗的临床近期疗效优于单纯切除。更多还原

【Abstract】 Objective To summarize the clinical effect of liver cancer with portal hypertension treated by combined operation.Methods From June 2000 to December 2008,32 patients of liver cancer with portal hypertension treated by combined operation compared with 26 patients of liver cancer with portal hypertension treated by simple excision at the same time,which was analyzed retrospectively in 1 year survival rate, 3 year survival rate, 5 year survival rate and re-bleeding rate. Results The combined team(n=32)has outstanding different than the simple excision team (n=26)in 1 year survival rate; 3 year survival rate and re-bleeding rate(P<0.05)excepting 5 year survival rate(P>0.05).Conclusion The clinical effect of liver cancer with portal hypertension treated by combined operation is better than which treated by the simple excision in recent period.更多还原